Overview

Link Pharmaceuticals' business as a whole is focused on marketing a diverse range of specialist and vitally important therapeutic products in Australia and New Zealand. 

Unless you are one of our customers, the chances are that you have not heard of us before.  However over the past decade Link has been quietly working on a strategy which centres on the acquisition of exclusive regional marketing rights to important products through the formation of long-term partnerships with global/regional pharmaceutical companies. 

With headquarters in Sydney and regional office in Auckland, Link Pharma. is able to provide an excellent service to both our customers and commercial partners. 

The Company's sucess is based on a decade of strong performance from the Pharmaceutical Division which has developed an impressive portfolio of acquired and in-licensed therapeutic products.

 

Link Group gains marketing approval for first oncology generic.

Link Pharmaceuticals announced approval to market the company’s generic vinorelbine product “Vinorelbine-Link”.

This is the first of a broad range of specialist products expected to join Link’s range in the coming year and moves the company closer to the goal of being a significant specialist pharmaceutical company in the Australasian region.